Real-World Experience of Immunotherapy from India in Recurrent Squamous Cell Carcinoma of Head and Neck Cancer

Real-World Experience of Immunotherapy from India in Recurrent Squamous Cell Carcinoma of Head and Neck Cancer

Background Recurrent metastatic head and neck squamous cell carcinoma (HNSCC) patients carry a poor prognosis and have limited therapeutic options. In the randomized phase-3 trial CheckMate 141, nivolumab showed benefit in overall survival (OS) with manageable toxicity. Nivolumab is available for cl...

Full description

Bibliographic Details
Main Authors: Waseem Abbas, Saurabh Gupta, Vineeta Goel, Ranga R. Rao, Promila Pankaj, Devashish Tripathi, Pratik P. Patil, Swati Popli
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-04-01
Series:South Asian Journal of Cancer
Subjects:
immunotherapy in head and neck cancers
immunotherapy in india
immunotherapy in recurrent head and neck cancers
treatment of cisplatin refractory head and neck cancers
treatment of recurrent head and neck cancers
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1729443

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1729443

Similar Items